Trusted Resources: Education
Scientific literature and patient education texts
Normal Scores of Deep Breathing Tests: Beware of Dysrhythmia in Transthyretin Amyloidosis
source: Amyloid: The International Journal of Experimental and Clinical Investigation
year: 2018
authors: Wiklund U, Kadkhodaee A, Andersson K, Suhr OB, Hörnsten R
summary/abstract:Background:
The heart rate (HR) response to paced deep breathing (DB) is a common test of cardiac autonomic function, where high heart rate variability (HRV) is considered to reflect normal autonomic function. We evaluated the DB test in patients with hereditary transthyretin amyloid (ATTRm) amyloidosis, where autonomic dysregulation and atrial arrhythmias are common.
Methods:
Paced DB was performed during one minute (six breaths/min) in 165 recordings in adult ATTRm amyloidosis patients with the TTR Val30Met mutation, 42 hypertrophic cardiomyopathy (HCM) patients and 211 healthy subjects. HRV was scored by traditional DB indices and by a novel regularity index, estimating the fraction of the HRV that was coherent with the breathing pattern.
Results:
Twenty per cent of ATTRm amyloidosis patients presented with age-adjusted HRV scores within normal limits but poor regularity due to subtle atrial arrhythmias and cardiac conduction disturbances. Forty-seven per cent of ATTRm amyloidosis patients presented with HRV scores below normal limits, whereas HCM patients presented with higher HRV than ATTRm amyloidosis patients.
Conclusions:
Reduced HRV is common in ATTRm amyloidosis patients during DB, however, autonomic function cannot be evaluated in patients presenting with the combination of “normal” scores and low regularity, since their HR responses often reflects dysrhythmias.
organization: Umeå University, SwedenDOI: 10.1080/13506129.2018.1434140
read more full text
Related Content
-
Dylan’s Amyloidosis Storyhttps://www.youtube.com/watch?v=G3Ec14rA...
-
Amyloidosis and the Heart: Patient InformationIn some patients with amyloidosis there ...
-
Stanford Amyloid Center: Kevin Anderson’s Storyhttps://www.youtube.com/watch?v=rfl0xWzg...
-
Alnylam Update on Clinical Trial for Hereditary TTR – ASG Webinar 9/11https://www.youtube.com/watch?v=K2TmwAfu...
-
Symptom Mangement in Cardiac Amyloidosis: Back to Basics – ASG Webinar 3/11https://www.youtube.com/watch?v=K2TmwAfu...
-
Stephen Heitner, MDStephen Heitner is a Senior Medical Dire...
-
Choosing Not to Continue Your Career After hATTR Amyloidosis DiagnosisDeciding to leave your job following you...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.